Literature DB >> 3753520

Inhibition of glutathione peroxidase and glutathione transferase in mouse liver by misonidazole.

K S Kumar, J F Weiss.   

Abstract

The mechanisms of toxicity and sensitization by the radiosensitizer misonidazole [1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol] are not well understood. We report here on the inhibition of total glutathione peroxidase (GSHPx), selenium-dependent glutathione peroxidase (selenium-GSHPx) and glutathione transferase (GSHTx) activities by misonidazole. Mouse liver cytosol GSHPx and selenium-GSHPx were inhibited in vitro with 0.5 mM misonidazole. On administration of the drug intraperitoneally (800 mg/kg) to mice, it was found that GSHPx, selenium-GSHPx, and GSHTx were inhibited in homogenate, cytosol, and microsomal fractions of mouse liver. GSHPx was depressed in all fractions up to 60-70% of control values, with maximum depression occurring in the cytosol and homogenate fractions in less than 2 hr. Recovery of activity was slower in the microsomes. In general, the pattern of depression of selenium-GSHPx was parallel to that of GSHPx except in microsomes, where GSHPx is minimal. Quantitatively, selenium-GSHPx was least affected. GSHTx was inhibited 70-80% of control values in cytosol and homogenate with recovery by 24 hr, whereas a second period of depression occurred at 24 hr in the microsomes. The inhibition of peroxide-metabolizing enzymes may lead to elevation of intracellular peroxide levels, contributing to the radiosensitizing effect and/or toxicity of misonidazole.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753520     DOI: 10.1016/0006-2952(86)90399-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Microwave-assisted synthesis and evaluation of acylhydrazones as potential inhibitors of bovine glutathione peroxidase.

Authors:  Felix Wilde; Heidi Lemmerhirt; Thomas Emmrich; Patrick J Bednarski; Andreas Link
Journal:  Mol Divers       Date:  2014-01-19       Impact factor: 2.943

2.  Solubility behavior, phase transition, and structure-based nucleation inhibition of etanidazole in aqueous solutions.

Authors:  M B Maurin; S M Rowe; K S Field; R C Swintosky; M A Hussain
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

Review 3.  Recent Progress in the Synthesis of Drugs and Bioactive Molecules Incorporating Nitro(het)arene Core.

Authors:  Maxim Bastrakov; Alexey Starosotnikov
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-03

Review 4.  The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics.

Authors:  J Seidegård; G Ekström
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

5.  Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide.

Authors:  P J O'Dwyer; F P LaCreta; J Walczak; T Cox; S Litwin; J P Hoffman; M Zimny; R L Comis
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.